Build Your Comparison

Side-by-side financial analysis
PRM logo
PRM
KWR logo
KWR
CBT logo
CBT
IOSP logo
IOSP
JPM logo
JPM
Try popular comparisons:

Stock Comparison

PRM vs KWR vs CBT vs IOSP vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PRM
Perimeter Solutions, S.A.

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$5.79B
5Y Perf.+201.9%
KWR
Quaker Chemical Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$2.50B
5Y Perf.-36.6%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.58B
5Y Perf.+67.0%
IOSP
Innospec Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$2.13B
5Y Perf.+6.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+101.9%

PRM vs KWR vs CBT vs IOSP vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PRM logoPRM
KWR logoKWR
CBT logoCBT
IOSP logoIOSP
JPM logoJPM
IndustryChemicals - SpecialtyChemicals - SpecialtyChemicals - SpecialtyChemicals - SpecialtyBanks - Diversified
Market Cap$5.79B$2.50B$4.58B$2.13B$896.00B
Revenue (TTM)$706M$1.93B$3.58B$1.79B$280.33B
Net Income (TTM)$-190M$4M$285M$114M$57.05B
Gross Margin56.4%34.4%24.8%27.4%60.0%
Operating Margin-20.5%3.7%15.7%8.1%25.9%
Forward P/E20.3x20.6x13.9x17.9x14.4x
Total Debt$34M$929M$1.22B$90M$942.38B
Cash & Equiv.$326M$180M$258M$293M$343.34B

PRM vs KWR vs CBT vs IOSP vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PRM
KWR
CBT
IOSP
JPM
StockNov 21Jun 26Return
Perimeter Solutions… (PRM)100301.9+201.9%
Quaker Chemical Cor… (KWR)10063.4-36.6%
Cabot Corporation (CBT)100167.0+67.0%
Innospec Inc. (IOSP)100106.6+6.6%
JPMorgan Chase & Co. (JPM)100201.9+101.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: PRM vs KWR vs CBT vs IOSP vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBT leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and dividend income and shareholder returns. Perimeter Solutions, S.A. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. IOSP and JPM also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇CBT emerged as the overall leader. Track its performance:
PRM
Perimeter Solutions, S.A.
The Growth Play

PRM is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 16.4%, EPS growth -32.8%, 3Y rev CAGR 21.9%
  • 16.4% revenue growth vs CBT's -7.0%
  • +164.1% vs IOSP's +1.4%
Best for: growth exposure
KWR
Quaker Chemical Corporation
The Basic Materials Pick

Among these 5 stocks, KWR doesn't own a clear edge in any measured category.

Best for: basic materials exposure
CBT
Cabot Corporation
The Income Pick

CBT carries the broadest edge in this set and is the clearest fit for income & stability.

  • Dividend streak 14 yrs, beta 0.82, yield 2.0%
  • Lower P/E (13.9x vs 20.6x)
  • 2.0% yield, 14-year raise streak, vs KWR's 1.4%, (1 stock pays no dividend)
  • 7.4% ROA vs PRM's -6.9%, ROIC 17.4% vs -11.6%
Best for: income & stability
IOSP
Innospec Inc.
The Defensive Pick

IOSP ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
  • PEG 0.56 vs JPM's 0.81
  • Beta 0.70, yield 2.0%, current ratio 2.79x
  • Beta 0.70 vs KWR's 1.36, lower leverage
Best for: sleep-well-at-night and valuation efficiency
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding.

  • 465.8% 10Y total return vs PRM's 195.6%
  • 20.4% margin vs PRM's -26.9%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthPRM logoPRM16.4% revenue growth vs CBT's -7.0%
ValueCBT logoCBTLower P/E (13.9x vs 20.6x)
Quality / MarginsJPM logoJPM20.4% margin vs PRM's -26.9%
Stability / SafetyIOSP logoIOSPBeta 0.70 vs KWR's 1.36, lower leverage
DividendsCBT logoCBT2.0% yield, 14-year raise streak, vs KWR's 1.4%, (1 stock pays no dividend)
Momentum (1Y)PRM logoPRM+164.1% vs IOSP's +1.4%
Efficiency (ROA)CBT logoCBT7.4% ROA vs PRM's -6.9%, ROIC 17.4% vs -11.6%

PRM vs KWR vs CBT vs IOSP vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PRMPerimeter Solutions, S.A.
FY 2025
Product
83.4%$544M
Service
16.6%$108M
Product and Service, Other
0.0%$145,000
KWRQuaker Chemical Corporation
FY 2025
Metalworking and Other
67.7%$1.3B
Metals
32.3%$611M
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B
IOSPInnospec Inc.
FY 2025
Fuel Specialties
39.5%$702M
Performance Chemicals
38.3%$681M
Oilfield Services
22.2%$395M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

PRM vs KWR vs CBT vs IOSP vs JPM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRMLAGGINGKWR

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 397.1x PRM's $706M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to PRM's -26.9%. On growth, PRM holds the edge at +73.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$706M$1.9B$3.6B$1.8B$280.3B
EBITDAEarnings before interest/tax-$102M$143M$731M$187M$81.4B
Net IncomeAfter-tax profit-$190M$4M$285M$114M$57.0B
Free Cash FlowCash after capex$86M$143M$459M$77M$100.9B
Gross MarginGross profit ÷ Revenue+56.4%+34.4%+24.8%+27.4%+60.0%
Operating MarginEBIT ÷ Revenue-20.5%+3.7%+15.7%+8.1%+25.9%
Net MarginNet income ÷ Revenue-26.9%+0.2%+8.0%+6.4%+20.4%
FCF MarginFCF ÷ Revenue+12.2%+7.4%+12.8%+4.3%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year+73.6%+8.5%-3.4%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+22.2%+54.8%-23.1%-6.9%+16.0%
JPM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

IOSP leads this category, winning 3 of 7 comparable metrics.

At 14.6x trailing earnings, CBT trades at a 21% valuation discount to IOSP's 18.5x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.58x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
Market CapShares × price$5.8B$2.5B$4.6B$2.1B$896.0B
Enterprise ValueMkt cap + debt − cash$5.5B$3.3B$5.5B$1.9B$1.50T
Trailing P/EPrice ÷ TTM EPS-25.89x-1031.86x14.56x18.54x16.00x
Forward P/EPrice ÷ next-FY EPS est.20.34x20.59x13.88x17.93x14.40x
PEG RatioP/E ÷ EPS growth rate0.58x0.90x
EV / EBITDAEnterprise value multiple12.03x7.14x9.39x18.36x
Price / SalesMarket cap ÷ Revenue8.86x1.33x1.23x1.20x3.20x
Price / BookPrice ÷ Book value/share4.66x1.83x2.79x1.62x2.47x
Price / FCFMarket cap ÷ FCF27.74x31.07x11.71x24.24x8.88x
IOSP leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

CBT leads this category, winning 6 of 9 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-16 for PRM. PRM carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs KWR's 4/9, reflecting solid financial health.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-16.4%+0.3%+16.8%+8.6%+15.9%
ROA (TTM)Return on assets-6.9%+0.2%+7.4%+6.3%+1.3%
ROICReturn on invested capital-11.6%+6.6%+17.4%+11.2%+4.5%
ROCEReturn on capital employed-8.3%+7.6%+21.3%+11.0%+8.9%
Piotroski ScoreFundamental quality 0–954665
Debt / EquityFinancial leverage0.03x0.67x0.71x0.07x2.60x
Net DebtTotal debt minus cash-$292M$749M$957M-$203M$599.0B
Cash & Equiv.Liquid assets$326M$180M$258M$293M$343.3B
Total DebtShort + long-term debt$34M$929M$1.2B$90M$942.4B
Interest CoverageEBIT ÷ Interest expense-5.17x1.41x14.72x0.74x
CBT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PRM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in PRM five years ago would be worth $29,558 today (with dividends reinvested), compared to $6,392 for KWR. Over the past 12 months, PRM leads with a +164.1% total return vs IOSP's +1.4%. The 3-year compound annual growth rate (CAGR) favors PRM at 78.1% vs KWR's -9.2% — a key indicator of consistent wealth creation.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+28.9%+4.7%+32.1%+14.7%-0.5%
1-Year ReturnPast 12 months+164.1%+22.7%+17.4%+1.4%+21.8%
3-Year ReturnCumulative with dividends+464.8%-25.1%+26.6%-7.8%+138.2%
5-Year ReturnCumulative with dividends+195.6%-36.1%+55.8%-4.2%+118.2%
10-Year ReturnCumulative with dividends+195.6%+77.9%+119.6%+105.2%+465.8%
CAGR (3Y)Annualised 3-year return+78.1%-9.2%+8.2%-2.7%+33.6%
PRM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — PRM and IOSP each lead in 1 of 2 comparable metrics.

IOSP is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than KWR's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRM currently trades 98.5% from its 52-week high vs KWR's 78.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5001.09x1.36x0.82x0.70x0.94x
52-Week HighHighest price in past year$36.01$183.00$89.46$92.14$337.25
52-Week LowLowest price in past year$13.05$111.32$58.33$65.58$262.71
% of 52W HighCurrent price vs 52-week peak+98.5%+78.9%+98.0%+94.0%+95.1%
RSI (14)Momentum oscillator 0–10066.753.557.071.759.1
Avg Volume (50D)Average daily shares traded1.2M151K382K176K7.0M
Evenly matched — PRM and IOSP each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KWR and CBT each lead in 1 of 2 comparable metrics.

Analyst consensus: PRM as "Buy", KWR as "Buy", CBT as "Buy", IOSP as "Hold", JPM as "Buy". Consensus price targets imply 32.8% upside for IOSP (target: $115) vs -1.9% for CBT (target: $86). For income investors, CBT offers the higher dividend yield at 2.02% vs KWR's 1.36%.

MetricPRM logoPRMPerimeter Solutio…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationIOSP logoIOSPInnospec Inc.JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldBuy
Price TargetConsensus 12-month target$37.00$176.75$86.00$115.00$339.75
# AnalystsCovering analysts21415961
Dividend YieldAnnual dividend ÷ price+1.4%+2.0%+2.0%+1.9%
Dividend StreakConsecutive years of raises018141215
Dividend / ShareAnnual DPS$1.97$1.77$1.70$5.95
Buyback YieldShare repurchases ÷ mkt cap+0.7%+1.7%+3.7%0.0%+3.9%
Evenly matched — KWR and CBT each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 1 of 6 categories (Income & Cash Flow). IOSP leads in 1 (Valuation Metrics). 2 tied.

Best OverallPerimeter Solutions, S.A. (PRM)Leads 1 of 6 categories
Loading custom metrics...

PRM vs KWR vs CBT vs IOSP vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PRM or KWR or CBT or IOSP or JPM a better buy right now?

For growth investors, Perimeter Solutions, S.

A. (PRM) is the stronger pick with 16. 4% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 14. 6x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate Perimeter Solutions, S. A. (PRM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PRM or KWR or CBT or IOSP or JPM?

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 14.

6x versus Innospec Inc. at 18. 5x. On forward P/E, Cabot Corporation is actually cheaper at 13. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 56x versus JPMorgan Chase & Co. 's 0. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — PRM or KWR or CBT or IOSP or JPM?

Over the past 5 years, Perimeter Solutions, S.

A. (PRM) delivered a total return of +195. 6%, compared to -36. 1% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: JPM returned +465. 8% versus KWR's +77. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PRM or KWR or CBT or IOSP or JPM?

By beta (market sensitivity over 5 years), Innospec Inc.

(IOSP) is the lower-risk stock at 0. 70β versus Quaker Chemical Corporation's 1. 36β — meaning KWR is approximately 96% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Perimeter Solutions, S. A. (PRM) carries a lower debt/equity ratio of 3% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PRM or KWR or CBT or IOSP or JPM?

By revenue growth (latest reported year), Perimeter Solutions, S.

A. (PRM) is pulling ahead at 16. 4% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -32. 8% for Perimeter Solutions, S. A.. Over a 3-year CAGR, PRM leads at 21. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PRM or KWR or CBT or IOSP or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -31. 6% for Perimeter Solutions, S. A. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -30. 8% for PRM. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PRM or KWR or CBT or IOSP or JPM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 56x versus JPMorgan Chase & Co. 's 0. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cabot Corporation (CBT) trades at 13. 9x forward P/E versus 20. 6x for Quaker Chemical Corporation — 6. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 32. 8% to $115. 00.

08

Which pays a better dividend — PRM or KWR or CBT or IOSP or JPM?

In this comparison, CBT (2.

0% yield), IOSP (2. 0% yield), JPM (1. 9% yield), KWR (1. 4% yield) pay a dividend. PRM does not pay a meaningful dividend and should not be held primarily for income.

09

Is PRM or KWR or CBT or IOSP or JPM better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Both have compounded well over 10 years (JPM: +465. 8%, PRM: +195. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PRM and KWR and CBT and IOSP and JPM?

These companies operate in different sectors (PRM (Basic Materials) and KWR (Basic Materials) and CBT (Basic Materials) and IOSP (Basic Materials) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PRM is a small-cap high-growth stock; KWR is a small-cap quality compounder stock; CBT is a small-cap deep-value stock; IOSP is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. KWR, CBT, IOSP, JPM pay a dividend while PRM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.